ライフサイエンスコーパス: molecular pathology

1 ular mechanisms of PP, STN1 and STN1-related molecular pathology.

2 gical dysfunction in terms of the underlying molecular pathology.

3 ique, as well as insight into the underlying molecular pathology.

4 so undertaking brain imaging and analysis of molecular pathology.

5 n improved understanding of subtype-specific molecular pathology.

6 RN caused by infection with EBV confirmed by molecular pathology.

7 outcomes, such as cellular epidemiology and molecular pathology.

8 oteomic study of a broad range of targets in molecular pathology.

9 e early stages, despite distinct patterns of molecular pathology.

10 ion of the spectrin cytoskeleton is a common molecular pathology.

11 whose primary interest is in another area of molecular pathology.

12 n RTT and TSC have allowed dissection of the molecular pathology.

13 s, with the aim of identifying approaches to molecular pathology.

14 ptional dysregulation and cell-type-specific molecular pathology.

15 f depressed subjects with a more homogeneous molecular pathology.

16 tempts will be crucial to the advancement of molecular pathology.

17 Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) guideline on molecular testing

18 and Genomics (ACMG) and the Association for Molecular Pathology (AMP) published guidelines for the a

19 and Genomics (ACMG) and the Association for Molecular Pathology (AMP) published updated standards an

20 etics and Genomics (ACMG) and Association of Molecular Pathology (AMP) recently published important n

21 American Pathologists (CAP), Association for Molecular Pathology (AMP), and the American Society of C

22 isease (AD) is characterized by two hallmark molecular pathologies: amyloid abeta1-42 and Tau neurofi

23 The complex nature of molecular pathology and biology necessitates biostatisti

24 r disease characterization and monitoring in molecular pathology and is expected to become a central

25 st that ApoE4 may increase susceptibility to molecular pathology and modulate the anatomic pattern of

26 models, but these models do not reflect the molecular pathology and progressive nature of PD that wo

27 Finally, we discuss how progress in molecular pathology and radiation biology may provide no

28 ons of responsibility in AMP (Association of Molecular Pathology) and is Chair of the CLSI's Area Com

29 new findings regarding the cellular origins, molecular pathology, and clinical features of histiocyti

30 Degeneracy means that several different molecular pathologies are individually sufficient to cau

31 tor of Clinical Laboratories and Director of Molecular Pathology at the Medical University of South C

32 d virus type 8-RS1 (AAV8-RS1) vector rescues molecular pathology at the photoreceptor-depolarizing bi

33 Molecular pathology cannot determine the overall impact

34 describe insights into the cells of origin, molecular pathology, clinical features, and treatment st

35 lesions of the pancreas and their underlying molecular pathology, current management guidelines for p

36 g point can be reached via several different molecular pathologies (degeneracy).

37 Recent advances in molecular pathology, diagnosis, and management of patien

38 es a number of recent advances regarding the molecular pathology, diagnosis, localization, and manage

39 d assessment of amyloid burden, gliosis, and molecular pathology during disease progression.

40 r inherited, but little is known about their molecular pathology, especially the sporadic forms.

41 recent decision in the case Association for Molecular Pathology et al. v.

42 induced cachexia model based on clinical and molecular pathology findings.

43 e lesions is an essential component of their molecular pathology, funding agencies should adopt polic

44 mical carcinogenesis, immunology, pathology, molecular pathology, genetics, oncology, and surgical on

45 This progress in our understanding of the molecular pathology has set the stage for clinically mea

46 In addition, new developments in diagnostic molecular pathology have been used to more readily ident

47 The two primary molecular pathologies in Alzheimer's disease are amyloid

48 The underlying molecular pathology in a considerable proportion of thes

49 n all 118 exons of the gene to determine the molecular pathology in a patient with DEB.

50 One way to image the molecular pathology in Alzheimer's disease is by positro

51 This study shows that the molecular pathology in patients with the distinctive cli

52 on in liver or kidney is the primary site of molecular pathology in peripheral tissues, has not been

53 Epidemiology, molecular pathology (including chemistry, biochemistry,

54 a number of clinical disorders with distinct molecular pathologies, including fragile X syndrome (FXS

55 Ideally, epidemiology and molecular pathology information together with experiment

56 Molecular pathology is certain to become important in th

57 opathy is rare, and our understanding of the molecular pathology is limited.

58 es in humans and mice, respectively, but the molecular pathology is unclear.

59 The new molecular pathology is yet another technique that can im

60 ing the respective roles of epidemiology and molecular pathology, it was noted that epidemiology allo

61 tis C virus (HCV) genotypes in a high-volume molecular pathology laboratory setting.

62 infectious disease testing done in a central molecular pathology laboratory under the leadership of a

63 infectious disease testing done in a central molecular pathology laboratory under the leadership of a

64 peptides might play an insidious role in the molecular pathologies of protein misfolding diseases.

65 then used the DII-VSD construct to probe the molecular pathology of 2 Brugada syndrome mutations (A73

66 Understanding the molecular pathology of a tumor and its linkage to behavi

67 ration and are relevant to understanding the molecular pathology of ADLD.

68 ntiation programs and in the development and molecular pathology of allergic asthma.

69 nction of Matrin3 should help to clarify the molecular pathology of ALS and other diseases caused by

70 illuminate common mechanisms, we discuss the molecular pathology of AxD astrocytes and compare that t

71 s of isoaspartate formation in cells and the molecular pathology of brain aging.

72 ry epithelial cell types to the etiology and molecular pathology of breast disease.

73 ests that a unifying principle governing the molecular pathology of cancer is the co-dependent aberra

74 stablishing a paradigm for understanding the molecular pathology of CCS disease.

75 f recombinant DNA technology in defining the molecular pathology of common disorders and of diagnosti

76 s, it is important to consider that so far a molecular pathology of cortical GABAergic neurons appear

77 An enhanced understanding of the molecular pathology of disease gained from genomic studi

78 our understanding and interpretation of the molecular pathology of diseases such as cancer.

79 to be hardly any closer to understanding the molecular pathology of DM than when the mutation was fir

80 and, in humans, may also be involved in the molecular pathology of Down syndrome.

81 n of helicase motif Ia but also provides the molecular pathology of FANCJ in related diseases.

82 Molecular pathology of forest trees for a long time lagg

83 perplasia, and could also be involved in the molecular pathology of GO.

84 an online resource for access to data on the molecular pathology of haemophilia A, replacing previous

85 r the cytoplasmic aggregation process in the molecular pathology of HD.

86 contribute to a deeper understanding of the molecular pathology of HHT [corrected] in particular and

87 Our findings define the molecular pathology of homozygous VP and suggest that mi

88 s review discusses new methods to define the molecular pathology of human disease with high-throughpu

89 Vital insight into the molecular pathology of I-GS has been obtained from studi

90 Here, we present the molecular pathology of IFN-gamma exposure and its effect

91 Several groups have studied the molecular pathology of inherited breast cancer.

92 P, and suggest reasonable hypotheses for the molecular pathology of inherited prion diseases.

93 ogical human cerebrovasculature to study the molecular pathology of intracranial aneurysms.

94 The molecular pathology of intraductal papillary mucinous ne

95 SorL1, SorCS1)] have been implicated in the molecular pathology of late-onset AD.

96 e as a valuable model both to understand the molecular pathology of late-onset retinal degeneration a

97 To better understand the molecular pathology of LINCL, we conducted a genetic sur

98 ssion would facilitate identification of the molecular pathology of major depression.

99 searchers hope that further knowledge of the molecular pathology of malignant gliomas will result in

100 Our results provide novel insight into the molecular pathology of microcephaly and establish a role

101 e precursor cells and of the stage-dependent molecular pathology of multiple sclerosis lesions releva

102 model provides a platform for dissecting the molecular pathology of oxidative damage in the outer ret

103 ography imaging is a tool to investigate the molecular pathology of PAH and its response to treatment

104 These data provide new insights into the molecular pathology of pancreatic cancer that may be use

105 al transcripts can provide insights into the molecular pathology of pancreatic cancer.

106 The molecular pathology of precursor lesions leading to inva

107 tic nerve were pursued for insights into the molecular pathology of primary open-angle glaucoma (POAG

108 Better understanding of the molecular pathology of PSP has highlighted the importanc

109 complexes, a process that is central to the molecular pathology of S. aureus endocarditis.

110 is leading to a better understanding of the molecular pathology of sarcomas, which may eventually le

111 As a step towards understanding the molecular pathology of SCA8, we have defined the genomic

112 herefore be considered when interpreting the molecular pathology of single-gene disorders.

113 Molecular pathology of skeletal muscle was ameliorated i

114 ing, will increasingly be used to define the molecular pathology of specific cases diagnosed with dep

115 Understanding the molecular pathology of the adenoma is therefore importan

116 a route to further our understanding of the molecular pathology of the condition.

117 In this work, we have explored the molecular pathology of the lethal form of EB-PA, and we

118 In addition to its role in the molecular pathology of the polyglutamine expansion disea

119 The type and molecular pathology of the thyroid tumors is changing wi

120 Major insights have been attained into the molecular pathology of the trinucleotide repeat neurodeg

121 To further explore the molecular pathology of this disease and to investigate p

122 s that will advance our understanding of the molecular pathology of this disease.

123 ces in our understanding of the genetics and molecular pathology of this group of diseases, as well a

124 to be highly informative in elucidating the molecular pathology of this highly malignant tumour type

125 Molecular pathology of thymomas is poorly understood.

126 The molecular pathology of type 3 VWD has been similarly wel

127 th which to study DNA repair, as well as the molecular pathology of UV radiation-induced skin cancer.

128 ing these relationships may help clarify the molecular pathology of various cardiovascular disease st

129 The molecular pathology of VUs remains poorly understood, im

130 Currently, little is known about the molecular pathology or cell biology of SCC in RDEB.

131 h a switch in spike initiation dynamics when molecular pathologies reach a tipping point (criticality

132 romising new approach for large scale cancer molecular pathology studies.

133 However, genomic, epigenomic and molecular pathology testings (for example, analyses for

134 ajor depression is reflected in a persistent molecular pathology that affects the amygdala, and suppo

135 ubtypes exist, yet little is known about the molecular pathology that drives the diversity in these t

136 -binding protein) identifies a novel type of molecular pathology that shows increasing accumulation i

137 strophies type 1 (DM1) and DM2 cause complex molecular pathology, the features of which include accum

138 However, the molecular pathology underlying ID-associated TRMT1 mutat

139 e linking GARS mutations to CMT disease, the molecular pathology underlying the neuromuscular and sen

140 se before the Supreme Court, Association for Molecular Pathology v Myriad Genetics, Inc seeks to over

141 The Association for Molecular Pathology v Myriad Supreme Court decision will

142 e Court's recent decision in Association for Molecular Pathology v. Myriad Genetics, Inc. declared, f

143 In the past 30 years, molecular pathology (which includes chemistry, biochemis

144 dementias has led to an understanding of the molecular pathology, which is also applicable to later-o

145 nal fluid biomarkers for Alzheimer's disease molecular pathology with clinical dementia diagnoses and